Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide in Short Bowel Syndrome
NCT01818648Phase 4Withdrawn
- Sponsor
- Mayo Clinic
- Start
- Mar 2013
- Primary completion
- Jan 2014
- Modality
- Peptides
01
Overview
A Phase 4 trial of exenatide in short bowel syndrome (SBS), sponsored by Mayo Clinic. Planned start Mar 2013; status: withdrawn.
02
Drugs
exenatide
03
Conditions
short bowel syndrome (SBS)
Beyond the preview
Go deeper on NCT01818648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01818648.